A key issue was the lack of a centralized, federally coordinated effort to ensure equitable distribution. Instead of having a national strategy for vaccine rollout, individual states and private companies managed the distribution, which led to inefficiencies and disparities. States like Florida and Texas, with large elderly populations, received large shipments of vaccines, while less affluent states, such as Michigan and Ohio, struggled to meet demand in high-risk communities.